Piper Sandler maintains Amneal Pharma A at 'overweight' with a price target of $5.00

  • Investing.com
Piper Sandler maintains Amneal Pharma A at 'overweight' with a price target of $5.00

An analyst from Piper Sandler maintained Amneal Pharma A (NYSE: AMRX ) at 'overweight' with a price target of $5.00 from a prior price target of %currency%%price%.

Prior to this rating, Amneal Pharma A had 4 buy ratings, 0 hold ratings, and 1 sell ratings.

For consensus analyst estimates and price targets on Amneal Pharma A, click here. For more news on Amneal Pharma A, click here.

Amneal Pharma A's stock price closed at $4.110. They are up 36.54% in the last month and up 31.310% in the last 12 months.

According to Investing Pro, Amneal Pharma A's fair value is $5.835, an upside of 41.968%. Amneal Pharma A's fair value comes with a medium degree of uncertainty, according to InvestingPro.

Check out Amneal Pharma A's recent earnings performance and financials here.

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100

Related Articles